Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.

PubWeight™: 1.99‹?› | Rank: Top 2%

🔗 View Article (PMC 2991118)

Published in J Am Coll Surg on October 01, 1998

Authors

S Iwatsuki1, S Todo, J W Marsh, J R Madariaga, R G Lee, I Dvorchik, J J Fung, T E Starzl

Author Affiliations

1: Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, PA 15213, USA.

Articles citing this

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95

Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23

Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol (2011) 2.11

Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg (2003) 2.03

Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg (2001) 1.99

Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99

Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology (2012) 1.70

Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg (2007) 1.58

Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg (2004) 1.35

Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther (2011) 1.06

Diagnostic approach to patients with cholestatic jaundice. World J Gastroenterol (1999) 1.02

Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01

Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol (2012) 0.97

Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg (2014) 0.97

Liver transplantation for non-hepatocellular carcinoma malignancy. HPB (Oxford) (2007) 0.93

Cholangiocarcinoma and its management. Gut (2007) 0.93

Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol (2009) 0.91

Radiofrequency ablation as a treatment for hilar cholangiocarcinoma. World J Gastroenterol (2008) 0.89

Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) (2011) 0.89

Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol (2007) 0.89

Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) (2008) 0.88

Update on the management of cholangiocarcinoma. Dig Dis (2014) 0.87

c-Met targeted therapy of cholangiocarcinoma. World J Gastroenterol (2008) 0.86

The costs of postoperative liver failure and the economic impact of liver function capacity after extended liver resection--a single-center experience. Langenbecks Arch Surg (2009) 0.86

The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB (Oxford) (2005) 0.84

Surgical management of proximal bile duct cancers. Langenbecks Arch Surg (2012) 0.83

Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int (2008) 0.83

Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol (2013) 0.83

Limits of Surgical Resection for Bile Duct Cancer. Viszeralmedizin (2015) 0.82

Cholangiocarcinoma: has there been any progress? Can J Gastroenterol (2010) 0.82

Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford) (2011) 0.82

Liver transplantation for cholangiocarcinoma: Current status and new insights. World J Hepatol (2015) 0.81

Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg (2003) 0.80

Cholangiocarcinoma: a 7-year experience at a single center in Greece. World J Gastroenterol (2008) 0.79

Diagnosis, Staging, and Treatment of Cholangiocarcinoma. Curr Treat Options Gastroenterol (2003) 0.79

Liver transplantation for hepatic tumors: a systematic review. World J Gastroenterol (2014) 0.78

Placement of ¹²⁵I seed strands and stents for a type IV Klatskin tumor. World J Gastroenterol (2015) 0.78

Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl (1998) 0.78

Changing trends of surgical treatment of hilar bile duct cancer: clinical and experimental perspectives. World J Gastroenterol (2000) 0.77

Liver transplantation(). J Ultrasound (2007) 0.77

Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) (2003) 0.77

Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg (2014) 0.76

Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg (2016) 0.75

Using the modern Silverhawk™ atherectomy catheter to characterize biliary structures that appear malignant: review of initial experience. HPB (Oxford) (2011) 0.75

Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma. World J Surg Oncol (2016) 0.75

Management of an unclear bile duct stenosis. Surg Endosc (2004) 0.75

Palliative decompression of obstructive hilar malignancies utilizing an extrahilar biliary approach. Dig Dis Sci (2000) 0.75

Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol (2017) 0.75

Articles cited by this

Evolution of liver transplantation. Hepatology (1982) 19.54

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42

ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med (1965) 4.22

Management strategies in resection for hilar cholangiocarcinoma. Ann Surg (1992) 3.69

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71

Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54

Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg (1981) 2.53

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg (1996) 2.35

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Left hepatic trisegmentectomy. Surg Gynecol Obstet (1982) 2.16

Outcome of radical surgery in hilar cholangiocarcinoma. Surgery (1990) 1.79

Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery (1994) 1.73

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg (1998) 1.72

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery (1995) 1.52

Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma. Br J Surg (1995) 1.48

What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43

Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg (1994) 1.10

Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract. Br J Surg (1994) 1.10

Extended bile duct resection--a new oncological approach to the treatment of central bile duct carcinomas? Description of method and early results. Langenbecks Arch Chir (1994) 0.99

Liver transplantation in Ohio. Surgery (1997) 0.82

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Examination and characterization of distribution system biofilms. Appl Environ Microbiol (1987) 5.85

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Occurrence of Giardia and Cryptosporidium spp. in surface water supplies. Appl Environ Microbiol (1991) 5.31

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Inactivation of biofilm bacteria. Appl Environ Microbiol (1988) 4.29

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16